Archive: 21/02/2019
New drug for Duchenne muscular dystrophy clears phase 1 clinical trial testing in boys
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant ...
Feb 21, 2019
Current tools have low accuracy for predicting delayed ischemia after aneurysmal subarachnoid hemorrhage
Both CT angiography and transcranial Doppler have limited accuracy in detecting cerebral vasospasm and predicting delayed cerebral ischemia (DCI) in patients with subarachnoid hemorrhage (SAH) due to ruptured aneurysm, reports ...
Feb 21, 2019